Vixarelimab, CAS 2243320-83-2

Product Description: Vixarelimab (KPL-716) is a human anti-oncostatin M (OSM) monoclonal antibody that binds to the beta chain of the OSM receptor and inhibits IL-31 and OSM signalling. Vixarelimab can be used in studies of inflammatory skin diseases such as atopic dermatitis and itchy nodular rash[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Carl D Richards, et al. Oncostatin M Induction of Monocyte Chemoattractant Protein 1 is Inhibited by Anti-oncostatin M Receptor Beta Monoclonal Antibody KPL-716. Acta Derm Venereol. 2020 Jul 2;100(14):adv00197.

CAS Number: 2243320-83-2

Molecular Weight: N/A

Compound Purity: 95.0

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Interleukin Related

• Artikelnummer: MEXHY-P99519-10
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99519-10
• Green Labware: Nein
• Verpackungseinheit: 10 mg
• Mengeneinheit: STK